International Conference on Personalised Cancer Screening in Riga

Throughout the day, participants explored topics such as the ethical and social implications of personalised screening, risk-based screening models for cervical, breast, colorectal, prostate, lung, and gastric cancers. Sessions also highlighted emerging technologies, including liquid biopsies, polygenic risk scores (PRS), and the role of artificial intelligence in screening. 
The final plenary session addressed the importance of effective communication and citizen engagement in implementing personalised cancer screening programmes across healthcare systems.

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.